Ticagrelor: a P2Y.sub.12 antagonist for use in acute coronary syndromes

• Published in: Expert review of clinical pharmacology Vol. 5; no. 3; p. 257
• Main Authors: Wijeyeratne, Yanushi Dullewe, Joshi, Rashi, Heptinstall, Stan
• Format: Journal Article
• Language: English
• Published: Expert Reviews Ltd 01.05.2012
• Subjects: Aspirin; Care and treatment; Coronary heart disease; Prevention; Trademarks

Agents that inhibit platelet function are used routinely in the treatment and prevention of acute coronary syndromes. The main antiplatelet treatments used combine aspirin with one of the thienopyridine P2Y.sub.12 antagonists, either clopidogrel or prasugrel. By blocking the synthesis of thromboxane...